- Home
- PASG vs DRIO Comparison
PASG vs DRIO Comparison
Compare PASG & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- DRIO
- Stock Information
- Founded
- PASG 2017
- DRIO 2011
- Country
- PASG United States
- DRIO United States
- Employees
- PASG N/A
- DRIO N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- PASG Health Care
- DRIO Health Care
- Exchange
- PASG Nasdaq
- DRIO Nasdaq
- Market Cap
- PASG 31.1M
- DRIO 27.9M
- IPO Year
- PASG 2020
- DRIO N/A
- Fundamental
- Price
- PASG $0.39
- DRIO $0.59
- Analyst Decision
- PASG Strong Buy
- DRIO Strong Buy
- Analyst Count
- PASG 3
- DRIO 1
- Target Price
- PASG $7.67
- DRIO $2.00
- AVG Volume (30 Days)
- PASG 162.1K
- DRIO 293.8K
- Earning Date
- PASG 03-04-2025
- DRIO 05-14-2025
- Dividend Yield
- PASG N/A
- DRIO N/A
- EPS Growth
- PASG N/A
- DRIO N/A
- EPS
- PASG N/A
- DRIO N/A
- Revenue
- PASG N/A
- DRIO $27,040,000.00
- Revenue This Year
- PASG N/A
- DRIO $22.40
- Revenue Next Year
- PASG N/A
- DRIO $21.41
- P/E Ratio
- PASG N/A
- DRIO N/A
- Revenue Growth
- PASG N/A
- DRIO 32.86
- 52 Week Low
- PASG $0.33
- DRIO $0.56
- 52 Week High
- PASG $1.64
- DRIO $1.93
- Technical
- Relative Strength Index (RSI)
- PASG 36.52
- DRIO 37.21
- Support Level
- PASG $0.33
- DRIO $0.62
- Resistance Level
- PASG $0.54
- DRIO $0.74
- Average True Range (ATR)
- PASG 0.05
- DRIO 0.05
- MACD
- PASG -0.00
- DRIO -0.01
- Stochastic Oscillator
- PASG 24.29
- DRIO 12.70
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.